TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Consultancies and service providers at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

9 consultancies and service providers are at TIDES Europe 2026 — 14 presentations on the program. Most represented: Livinovea (1 on the program), Coswald Consulting (1 on the program), ML Consult (1 on the program). 4 of them have their own page in this guide. As of Nov 2, 2026.

All 167 organizations at TIDES Europe 2026 →

Focus
Top represented
Showing 1–9 of 9 organizations
OrganizationTIDES Europe 2026 Attendance
Consulting & services
Swiss consultancy providing business, operational and technical support, including tech transfer and process optimization, to pharma, biotech and CDMOs.
Talk
Tue Nov 3
09:45–10:25
Oligonucleotide Economics from Molecule Design and CMC to Patient-Year Cost
Workshop #1:CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
Chair
Tue Nov 3
09:00–09:05
Workshop Moderators’ Introduction
Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken.
with Axolabs
Chair
Thu Nov 5
08:00–08:05
Chairwoman's Remarks: Innovations in Oligonucleotide CMC
Oligonucleotide Chemistry, Manufacturing & Controls
Consulting & services
Consultancy helping drug manufacturers improve quality and production systems, including chemistry, manufacturing and controls for oligonucleotides.
Talk
Tue Nov 3
11:25–12:00
Drug Substance and Drug Product Examples and Applications
Workshop #2:Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market
Keynote
Tue Nov 3
09:00–09:10
Moderator’s Welcome and Opening Remarks
Why manufacturing and quality planning for oligonucleotide drugs should start early and span test methods, chemistry choices and raw-material supply.
Consulting & services
Consultancy working on oligonucleotide chemistry, manufacturing and controls from the early discovery stage onward.
Talk
Tue Nov 3
09:10–09:45
Drug Substance and Drug Product and How CMC Early in the Discovery Lifecycle Can Help
Why a careful handover from making the drug substance to making the finished product makes the paperwork for first clinical trials easier.
Chair
Thu Nov 5
13:55–14:00
Chairman's Remarks: Oligonucleotide Preclinical and Clinical Updates
Oligonucleotide Discovery, Preclinical and Clinical · with Sheba Medical Center
Consulting & services
Consultancy advising on oligonucleotide manufacturing and sourcing nucleic acid raw materials for drug and diagnostics developers.
Chair
Tue Nov 3
13:10–13:15
Chairperson’s Remarks
Keynote Sessions - MAIN CONFERENCE
OligonucleotidesPeptides
Chair
Wed Nov 4
13:55–14:00
Chairman’s Remarks: Emerging Technologies in Oligonucleotide Manufacturing
Oligonucleotide Chemistry, Manufacturing & Controls
Drees & Sommer
Stuttgart, Germany
Consulting & services
Engineering, consulting and project management firm that plans and builds facilities, including life science manufacturing sites.
Talk
Wed Nov 4
11:15–11:45
Enzymatic Ligation and Manufacturing Microbial Control Consdierations
How joining oligonucleotide pieces with enzymes in water-based steps raises new risks of microbial growth, and what that means for regulated manufacturing.
Informa Connect
London, United Kingdom
Consulting & services
Event organizer that runs TIDES Europe, its Obesity Science & Innovation Europe symposium and other life science conferences.
Talk
Fri Nov 6
08:30–08:40
Obesity Science & Innovation Europe Welcome
Post-event symposium: Opening Keynote Plenary
Consulting & services
Life sciences consultancy advising biotech and pharmaceutical companies on CMC and regulatory strategy.
Talk
Tue Nov 3
09:45–10:20
Future-Proofing Oligonucleotide Manufacturing: Starting-Material Strategy for Scale-Up, Platform Change, and Commercial Supply Continuity
Why the choice and control of starting materials decides whether oligonucleotide manufacturing survives scale-up, a platform switch or a site transfer.
MW
Mike Webb Pharma
Consulting & services
Consultancy advising on oligonucleotide CMC development, analysis and manufacture from preclinical work to marketing submission.
Chair
Thu Nov 5
13:55–14:00
Chairman's Remarks: Delivery, Analytical and CMC Strategies for Oligonucleotides
Oligonucleotide Chemistry, Manufacturing & Controls
SB
Sinawali Biotechnology Solutions
Consulting & services
Consultancy working on bioanalytical and analytical methods for oligonucleotide, mRNA and antibody-conjugated oligonucleotide drugs.
Talk
Tue Nov 3
10:50–11:25
Bioanalytical and Analytical Approaches and Alignment
A review of the now-standard laboratory tests for oligonucleotide drugs, and what changes for mRNA and for oligonucleotides attached to antibodies.

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from consultancies and service providers

Tell us what you sell and we’ll find the people at these consultancies and service providers most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse TIDES Europe 2026 by

Exhibit hall

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction